Evaluating serum cyclooxygenase-2 and vascular endothelial growth factor as biomarkers for endometriosis severity in reproductive-age women
Narra J · 2026
DOI: 10.52225/narra.v6i1.2984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Narra J, 2026. Verfasst von Aga Aslam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Hauptthemen laut MEDLINE: Endometriosis, Cyclooxygenase 2, Vascular Endothelial Growth Factor A. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Endometriosis affects approximately 10–15% of reproductive-age women and up to 70% of those with chronic pelvic pain, with diagnosis typically relying on invasive laparoscopy with histopathological confirmation. Cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) are central mediators of the inflammatory and angiogenic pathways underpinning endometriosis pathogenesis, making them promising candidates for non-invasive biomarkers. This study aimed to analyze the correlation between serum COX-2 and VEGF concentrations and endometriosis severity to evaluate their potential utility as non-invasive biomarkers. A cross-sectional study was conducted among women with confirmed endometriosis at Dr. Zainoel Abidin General Hospital in Banda Aceh, Indonesia, in 2025. Peripheral blood samples were collected preoperatively, and serum COX-2 and VEGF concentrations were quantified using ELISA. Endometriosis severity was classified according to the American Society for Reproductive Medicine staging system. Correlation analyses were performed to assess associations between biomarker levels and disease stage, and diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis to determine the area under the curve (AUC) values, optimal cut-off points, sensitivity, and specificity. Twenty-eight patients were included, with the mean COX-2 and VEGF levels being 1.16±1.28 ng/mL and 266.50±72.91 pg/mL, respectively. VEGF demonstrated a strong and statistically significant correlation with endometriosis staging (r=0.744, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Dr. Zainoel Abidin General Hospital, Banda Aceh, Indonesia.
Zitieren
APA
Aslam, A., Rajuddin, R., Munizar, M., Rusnaidi, R., & Hasanuddin, H. (2026). Evaluating serum cyclooxygenase-2 and vascular endothelial growth factor as biomarkers for endometriosis severity in reproductive-age women. Narra J. https://doi.org/10.52225/narra.v6i1.2984
Vancouver
Aslam A, Rajuddin R, Munizar M, Rusnaidi R, Hasanuddin H. Evaluating serum cyclooxygenase-2 and vascular endothelial growth factor as biomarkers for endometriosis severity in reproductive-age women. Narra J. 2026. doi:10.52225/narra.v6i1.2984
BibTeX
@article{Aslam2026,
author = {Aslam, Aga and Rajuddin, Rajuddin and Munizar, Munizar and Rusnaidi, Rusnaidi and Hasanuddin, Hasanuddin},
title = {Evaluating serum cyclooxygenase-2 and vascular endothelial growth factor as biomarkers for endometriosis severity in reproductive-age women},
journal = {Narra J},
year = {2026},
doi = {10.52225/narra.v6i1.2984}
}
EUVIMED